# Pharmacotherapy & CM for Opioid and Cocaine Dependence

> **NCT00838981** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 91 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Sugar Pill
- **BEHAVIORAL:** Contingency Management
- **DRUG:** Methadone
- **BEHAVIORAL:** cognitive behavioral treatment
- **BEHAVIORAL:** Voucher Control

## Key facts

- **NCT ID:** NCT00838981
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2021-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838981, "Pharmacotherapy & CM for Opioid and Cocaine Dependence". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00838981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*